Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation.
Duléry R, Malard F, Brissot E, Banet A, Sestili S, Belhocine R, Calabro M, Van de Wyngaert Z, Bonnin A, Ledraa T, Legrand O, Labopin M, Capderou E, Cohen A, Ederhy S, Mohty M. Duléry R, et al. Among authors: banet a. Bone Marrow Transplant. 2023 Nov;58(11):1215-1222. doi: 10.1038/s41409-023-02085-2. Epub 2023 Aug 18. Bone Marrow Transplant. 2023. PMID: 37596473
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
Duléry R, Bastos J, Paviglianiti A, Malard F, Brissot E, Battipaglia G, Médiavilla C, Giannotti F, Banet A, de Wyngaert ZV, Ledraa T, Belhocine R, Sestili S, Adaeva R, Lapusan S, Isnard F, Legrand O, Vekhoff A, Rubio MT, Ruggeri A, Mohty M. Duléry R, et al. Among authors: banet a. Biol Blood Marrow Transplant. 2019 Jul;25(7):1407-1415. doi: 10.1016/j.bbmt.2019.02.025. Epub 2019 Mar 11. Biol Blood Marrow Transplant. 2019. PMID: 30871978 Free article. Clinical Trial.
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graft.
Stocker N, Gaugler B, Labopin M, Farge A, Ye Y, Ricard L, Brissot E, Duléry R, Sestili S, Battipaglia G, Médiavilla C, Paviglianiti A, Banet A, Van De Wyngaert Z, Ledraa T, Mohty M, Malard F. Stocker N, et al. Among authors: banet a. Clin Transl Immunology. 2020 Sep 23;9(9):e1171. doi: 10.1002/cti2.1171. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33005413 Free PMC article.
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation.
Duléry R, Mohty R, Labopin M, Sestili S, Malard F, Brissot E, Battipaglia G, Médiavilla C, Banet A, Van de Wyngaert Z, Paviglianiti A, Belhocine R, Isnard F, Lapusan S, Adaeva R, Vekhoff A, Ledraa T, Legrand O, Cohen A, Bonnin A, Ederhy S, Mohty M. Duléry R, et al. Among authors: banet a. JACC CardioOncol. 2021 Jun 15;3(2):250-259. doi: 10.1016/j.jaccao.2021.02.011. eCollection 2021 Jun. JACC CardioOncol. 2021. PMID: 34396331 Free PMC article.
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation.
Banet A, Bazarbachi A, Labopin M, Stocker N, Duléry R, Malard F, Van de Wyngaert Z, Genthon A, Memoli M, Legrand O, Bonnin A, Ledraa T, Belhocine R, Sestili S, El-Cheikh J, Mohty M, Brissot E. Banet A, et al. Bone Marrow Transplant. 2023 Jan;58(1):61-67. doi: 10.1038/s41409-022-01841-0. Epub 2022 Oct 12. Bone Marrow Transplant. 2023. PMID: 36224494
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Duléry R, Goudet C, Mannina D, Bianchessi A, Granata A, Harbi S, Maisano V, Chabannon C, Malard F, Brissot E, Sestili S, Banet A, Van de Wyngaert Z, Belhocine R, Ederhy S, Castagna L, Bramanti S, Blaise D, Mohty M, Fürst S, Devillier R. Duléry R, et al. Among authors: banet a. Bone Marrow Transplant. 2023 Apr;58(4):386-392. doi: 10.1038/s41409-022-01908-y. Epub 2022 Dec 30. Bone Marrow Transplant. 2023. PMID: 36585459
Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma.
Malard F, Battipaglia G, Gaugler B, Siblany L, van de Wyngaert Z, Bonnin A, Duléry R, Banet A, Stocker N, Ricard L, Brissot E, Mohty M. Malard F, et al. Among authors: banet a. Bone Marrow Transplant. 2023 Nov;58(11):1275-1278. doi: 10.1038/s41409-023-02078-1. Epub 2023 Aug 22. Bone Marrow Transplant. 2023. PMID: 37608072 No abstract available.
COVID-19 outcomes in patients with hematologic disease.
Malard F, Genthon A, Brissot E, van de Wyngaert Z, Marjanovic Z, Ikhlef S, Banet A, Lapusan S, Sestilli S, Corre E, Paviglianiti A, Adaeva R, M 'Hammedi-Bouzina F, Labopin M, Legrand O, Dulery R, Mohty M. Malard F, et al. Among authors: banet a. Bone Marrow Transplant. 2020 Nov;55(11):2180-2184. doi: 10.1038/s41409-020-0931-4. Epub 2020 May 6. Bone Marrow Transplant. 2020. PMID: 32376969 Free PMC article. No abstract available.
Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience.
Sestili S, Eder S, Belhocine R, Dulery R, Battipaglia G, Brissot E, Mediavilla C, Banet A, van de Wyngaert Z, Paviglianiti A, Ledraa T, Bonin A, Mohty M, Malard F. Sestili S, et al. Among authors: banet a. Cytotherapy. 2020 Aug;22(8):445-449. doi: 10.1016/j.jcyt.2020.03.003. Epub 2020 May 18. Cytotherapy. 2020. PMID: 32434750
Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation.
Genthon A, Brissot E, Malard F, van de Wyngaert Z, Bonnin A, Banet A, Marjanovic Z, Ikhlef S, Lapusan S, Sestili S, Corre E, Paviglianiti A, Adaeva R, 'Hammedi-Bouzina FM, Labopin M, Dulery R, Mohty M, Legrand O. Genthon A, et al. Among authors: banet a. Clin Lymphoma Myeloma Leuk. 2020 Dec;20(12):791-796. doi: 10.1016/j.clml.2020.07.001. Epub 2020 Jul 6. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32741743
30 results